ADMA Biologics
ADMA
#4079
Rank
NZ$5.38 B
Marketcap
NZ$24.27
Share price
-1.62%
Change (1 day)
-14.57%
Change (1 year)

Earnings for ADMA Biologics (ADMA)

Earnings in 2026 (TTM): NZ$0.42 Billion

According to ADMA Biologics 's latest financial reports the company's current earnings are NZ$0.51 Billion. In 2025 the company made an earning of NZ$0.34 Billion, an increase over its 2024 earnings that were of NZ$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ADMA Biologics from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.42 B24.3%
2025 NZ$0.34 B35.89%
2024 NZ$0.25 B-4446.66%
2023 -NZ$5.85 Million-93.11%
2022 -NZ$84.83 Million-20.42%
2021 -NZ$0.11 Billion-8.11%
2020 -NZ$0.12 Billion62.31%
2019 -NZ$71.48 Million-34.76%
2018 -NZ$0.11 Billion48.79%
2017 -NZ$73.64 Million134.28%
2016 -NZ$31.43 Million7.12%
2015 -NZ$29.35 Million0.3%
2014 -NZ$29.26 Million7.85%
2013 -NZ$27.13 Million71.04%
2012 -NZ$15.86 Million28864%
2011 -NZ$0.06 Million35.22%
2010 -NZ$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
NZ$55.81 M-87.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.41 Billion-191.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$40.5 Million-109.08%๐Ÿ‡บ๐Ÿ‡ธ USA